DE69715866D1 - Synthetische polysaccharide, verfahren zu deren herstellung und diese enthaltende, pharmazeutische zusammensetzungen - Google Patents

Synthetische polysaccharide, verfahren zu deren herstellung und diese enthaltende, pharmazeutische zusammensetzungen

Info

Publication number
DE69715866D1
DE69715866D1 DE69715866T DE69715866T DE69715866D1 DE 69715866 D1 DE69715866 D1 DE 69715866D1 DE 69715866 T DE69715866 T DE 69715866T DE 69715866 T DE69715866 T DE 69715866T DE 69715866 D1 DE69715866 D1 DE 69715866D1
Authority
DE
Germany
Prior art keywords
production
same
pharmaceutical compositions
compositions containing
synthetic polysaccharides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69715866T
Other languages
English (en)
Other versions
DE69715866T2 (de
Inventor
Alexandre Driguez
Philippe Duchaussoy
Jean-Marc Herbert
Maurice Petitou
Boeckel Constant Van
Peter Grootenhuis
Cornelia Dreef-Tromp
Johannes Basten
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Synthelabo SA
Akzo Nobel NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo SA, Akzo Nobel NV filed Critical Sanofi Synthelabo SA
Application granted granted Critical
Publication of DE69715866D1 publication Critical patent/DE69715866D1/de
Publication of DE69715866T2 publication Critical patent/DE69715866T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69715866T 1996-07-19 1997-07-18 Synthetische polysaccharide, verfahren zu deren herstellung und diese enthaltende, pharmazeutische zusammensetzungen Expired - Lifetime DE69715866T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9609116A FR2751334B1 (fr) 1996-07-19 1996-07-19 Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant
PCT/FR1997/001344 WO1998003554A1 (fr) 1996-07-19 1997-07-18 Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant

Publications (2)

Publication Number Publication Date
DE69715866D1 true DE69715866D1 (de) 2002-10-31
DE69715866T2 DE69715866T2 (de) 2003-05-28

Family

ID=9494266

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69715866T Expired - Lifetime DE69715866T2 (de) 1996-07-19 1997-07-18 Synthetische polysaccharide, verfahren zu deren herstellung und diese enthaltende, pharmazeutische zusammensetzungen

Country Status (36)

Country Link
US (1) US6534481B1 (de)
EP (1) EP0912613B1 (de)
JP (1) JP3345020B2 (de)
KR (1) KR100311857B1 (de)
CN (1) CN1200003C (de)
AR (1) AR008068A1 (de)
AT (1) ATE224917T1 (de)
AU (1) AU726679B2 (de)
BR (1) BR9710739B1 (de)
CA (1) CA2261597C (de)
CZ (1) CZ301009B6 (de)
DE (1) DE69715866T2 (de)
DK (1) DK0912613T3 (de)
EE (1) EE03929B1 (de)
ES (1) ES2184123T3 (de)
FR (1) FR2751334B1 (de)
HK (1) HK1019757A1 (de)
HU (1) HU223691B1 (de)
ID (1) ID20604A (de)
IL (2) IL128018A0 (de)
IS (1) IS1968B (de)
MY (1) MY124548A (de)
NO (1) NO319682B1 (de)
NZ (1) NZ333721A (de)
PL (1) PL190397B1 (de)
PT (1) PT912613E (de)
RU (1) RU2167163C2 (de)
SA (1) SA99200037B1 (de)
SI (1) SI0912613T1 (de)
SK (1) SK284881B6 (de)
TR (1) TR199900114T2 (de)
TW (1) TW520376B (de)
UA (1) UA61921C2 (de)
WO (1) WO1998003554A1 (de)
YU (1) YU49247B (de)
ZA (1) ZA976340B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2773801B1 (fr) 1998-01-19 2000-05-12 Sanofi Sa Nouveaux pentasaccharides, procedes pour leurs preparations et compositions pharmaceutiques les contenant
FR2814463B1 (fr) * 2000-09-22 2002-11-15 Sanofi Synthelabo Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine
US7138531B2 (en) * 2001-10-15 2006-11-21 Kemin Pharma B.V.B.A. Preparation and use of carbohydrate-based bicyclic ring structures with antimicrobial and cytostatic activity
EP1574516A1 (de) * 2004-03-05 2005-09-14 Sanofi-Aventis Antithrombotische Verbindungen
US7563780B1 (en) * 2004-06-18 2009-07-21 Advanced Cardiovascular Systems, Inc. Heparin prodrugs and drug delivery stents formed therefrom
FR2874924B1 (fr) * 2004-09-09 2006-12-01 Sanofi Aventis Sa Hexadecasaccharides biotinyles, leur preparation et leur utilisation therapeutique
TWI403334B (zh) * 2004-12-23 2013-08-01 Merck Sharp & Dohme 包含生物素殘基之抗血栓雙重抑制劑
TWI376234B (en) * 2005-02-01 2012-11-11 Msd Oss Bv Conjugates of a polypeptide and an oligosaccharide
IL181431A0 (en) * 2007-02-19 2007-07-04 Micha Shemer Fruit juice and puree with a lowered amount of available sugars
MX338213B (es) 2007-10-16 2016-04-07 Progen Pharmaceuticals Ltd Derivados de oligosacaridos sulfatados novedosos.
WO2009155108A1 (en) 2008-05-30 2009-12-23 Momenta Pharmaceuticals, Inc. Saccharide structures and methods of making and using such structures
FR2935386B1 (fr) * 2008-08-26 2010-09-10 Sanofi Aventis Nouveaux polysaccharides a activite antithrombotique comprenant une liaion covalente avec une chaine amine
WO2011014793A2 (en) 2009-07-31 2011-02-03 Reliable Biopharmaceutical Corporation Process for preparing fondaparinux sodium and intermediates useful in the synthesis thereof
FR2949114B1 (fr) 2009-08-14 2011-08-26 Sanofi Aventis OCTASACCHARIDES N-ACYLES ACTIVATEURS DES RECEPTEURS DES FGFs, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2949115B1 (fr) 2009-08-14 2012-11-02 Sanofi Aventis OLIGOSACCHARIDES N-SULFATES ACTIVATEURS DES RECEPTEURS DES FGFs, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
US8420790B2 (en) 2009-10-30 2013-04-16 Reliable Biopharmaceutical Corporation Efficient and scalable process for the manufacture of Fondaparinux sodium
KR101682466B1 (ko) * 2010-02-01 2016-12-05 롯데정밀화학 주식회사 아세틸화 셀룰로오스 에테르 및 이를 포함하는 물품
JP2013537181A (ja) 2010-09-10 2013-09-30 サノフイ 抗血栓活性及び改善された代謝安定性を有するビオチン化多糖類
FR2970969B1 (fr) 2011-01-27 2013-10-18 Sanofi Aventis Oligosaccharides 3-o-alkyles activateurs des recepteurs des fgfs, leur preparation et leur application en therapeutique
CN109134554B (zh) * 2017-06-15 2021-09-28 南京正大天晴制药有限公司 抗凝血的五糖类化合物及其制备方法和医药用途
CN109134553B (zh) * 2017-06-15 2021-09-28 南京正大天晴制药有限公司 抗凝血的五糖类化合物及其制备方法和医药用途
CN109134555B (zh) * 2017-06-15 2021-09-28 南京正大天晴制药有限公司 抗凝血的五糖类化合物及其制备方法和医药用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4801583A (en) 1982-01-15 1989-01-31 Choay S.A. Oligosaccharides and their biological applications
EP0300099A1 (de) 1987-07-20 1989-01-25 Akzo N.V. Pentasaccharide
US5382570A (en) 1990-04-23 1995-01-17 Akzo, N.V. Sulfated glycosaminoglycanoid derivatives of the dermatan sulfate and chondroitin sulfate type
US5378829A (en) 1990-04-23 1995-01-03 Akzo N.V. Sulfated glycosaminoglycanoid derivatives of the heparin and heparan sulfate type
IL102758A (en) 1991-08-23 1997-03-18 Akzo Nv Glycosaminoglycanoid derivatives, their preparation and pharmaceutical compositions comprising them
FR2704226B1 (fr) 1993-04-22 1995-07-21 Sanofi Elf 3-desoxy oligosaccharides, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
ATE190619T1 (de) 1993-09-01 2000-04-15 Akzo Nobel Nv Biskonjugate, die zwei saccharide und einen spacer enthalten
FR2749849B1 (fr) * 1996-06-14 1998-09-04 Sanofi Sa Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
ZA976340B (en) 1999-01-22
CN1200003C (zh) 2005-05-04
FR2751334B1 (fr) 1998-10-16
SK284881B6 (sk) 2006-02-02
CA2261597C (fr) 2004-12-14
JP2000500807A (ja) 2000-01-25
ATE224917T1 (de) 2002-10-15
YU49247B (sh) 2004-12-31
NO990215D0 (no) 1999-01-18
HK1019757A1 (en) 2000-02-25
IL128018A (en) 2007-10-31
CZ301009B6 (cs) 2009-10-14
US6534481B1 (en) 2003-03-18
KR100311857B1 (ko) 2001-11-14
HUP9902287A3 (en) 2001-09-28
HU223691B1 (hu) 2004-12-28
SA99200037B1 (ar) 2006-08-23
TR199900114T2 (xx) 1999-03-22
DE69715866T2 (de) 2003-05-28
PT912613E (pt) 2003-01-31
JP3345020B2 (ja) 2002-11-18
RU2167163C2 (ru) 2001-05-20
BR9710739B1 (pt) 2008-11-18
UA61921C2 (uk) 2003-12-15
TW520376B (en) 2003-02-11
IS4945A (is) 1999-01-18
AU726679B2 (en) 2000-11-16
PL190397B1 (pl) 2005-12-30
PL331259A1 (en) 1999-07-05
AR008068A1 (es) 1999-12-09
IS1968B (is) 2004-12-15
AU3774797A (en) 1998-02-10
IL128018A0 (en) 1999-11-30
BR9710739A (pt) 1999-08-17
CA2261597A1 (fr) 1998-01-29
ID20604A (id) 1999-01-21
SI0912613T1 (en) 2003-04-30
NO319682B1 (no) 2005-09-05
ES2184123T3 (es) 2003-04-01
SK5399A3 (en) 2000-05-16
DK0912613T3 (da) 2003-01-27
CN1228785A (zh) 1999-09-15
NZ333721A (en) 2000-08-25
CZ16099A3 (cs) 1999-06-16
EP0912613B1 (de) 2002-09-25
YU1999A (sh) 2000-03-21
FR2751334A1 (fr) 1998-01-23
KR20000067909A (ko) 2000-11-25
EE9900015A (et) 1999-08-16
NO990215L (no) 1999-03-18
EP0912613A1 (de) 1999-05-06
EE03929B1 (et) 2002-12-16
WO1998003554A1 (fr) 1998-01-29
HUP9902287A1 (hu) 1999-10-28
MY124548A (en) 2006-06-30

Similar Documents

Publication Publication Date Title
DE69715866D1 (de) Synthetische polysaccharide, verfahren zu deren herstellung und diese enthaltende, pharmazeutische zusammensetzungen
ATE187167T1 (de) Amido-3-pyrazol-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
DE69622992D1 (de) Substituierte heterocyclische verbindungen, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen
ATE317688T1 (de) Orale pharmazeutische zusammensetzung enthaltend ein benzimidazolderivat mit antiulcus wirkung und verfahren zu seiner herstellung
ATE234291T1 (de) Metallproteinasehemmer, diesen enthaltende pharmazeutische zusammensetzung und dessen pharmazeutische verwendung und verfahren zu ihrer herstellung
ATE245171T1 (de) Methyliden-malonat nanopartikel, verfahren zu deren herstellung, und diese enthaltende pharmazeutische praeparate
DE69902535D1 (de) Phenoxypropanolamin-derivate, verfahren zu ihrer herstellung und diese enthaltenden pharmazeutischen zusammensetzungen
ATE252562T1 (de) Pyrazolcarbonsäurederivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
ATE355266T1 (de) Neue acylierte pseudodipeptide, verfahren zu ihrer herstellung, und diese enthaltende pharmazeutische zusammensetzungen
DE69939959D1 (de) Polymer, Verfahren zu seiner Herstellung und Zusammensetzung
DE69900718D1 (de) Synthetische polysaccharide, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE69130221D1 (de) Oligosaccharidoxazolines, konjugate von oligosacchariden und verfahren zu ihrer herstellung
ATE150033T1 (de) N,o-sulfatierte heparosane; verfahren zu deren herstellung und diese enthaltende arzneimittel
ATE219069T1 (de) Neue arylglycinamidderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
DE60029337D1 (de) Celluloseether und verfahren zu deren herstellung
DE3680877D1 (de) Thiazolverbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE3777122D1 (de) Alkansulfonanilid-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE69934781D1 (de) Morphinsulfat enthaltende mikrogranulate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen
ATE143010T1 (de) Pyridazin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE69736396D1 (de) Sphärische Teilchen, Verfahren zu deren Herstellung und pharmazeutische ZUsammensetzungen mit diesen
ATE544448T1 (de) Morphinsulfat enthaltende mikrogranulate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen
DE69938787D1 (de) Molekularsiebe und verfahren zu deren herstellung
ATA260590A (de) Glyzerinderivate, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
DE60022890D1 (de) Naphthyridine derivate, verfahren zu ihrer herstellung, deren anwendung und sie enthaltende pharmazeutische zusammensetzungen
DE69520870D1 (de) Esculetin Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammenstellung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SANOFI-SYNTHELABO, PARIS, FR

8327 Change in the person/name/address of the patent owner

Owner name: SANOFI-AVENTIS, PARIS, FR

R082 Change of representative

Ref document number: 912613

Country of ref document: EP

Representative=s name: TER MEER STEINMEISTER & PARTNER GBR PATENTANWA, DE